EMILY KRUSE: Open Payments
NPI 1295109478 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$859 in 38 payments from 16 companies in 2025. Trend: 2023 $936 · 2024 $933 · 2025 $859
Food & beverage: $787Education: $72
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 5 | $171 |
| Lilly USA, LLC | 5 | $111 |
| Amgen Inc. | 6 | $98 |
| Janssen Biotech, Inc. | 2 | $95 |
| Regeneron Healthcare Solutions, Inc. | 4 | $92 |
| Novartis Pharmaceuticals Corporation | 3 | $44 |
| UCB, Inc. | 2 | $38 |
| PFIZER INC. | 2 | $35 |
| Arcutis Biotherapeutics, Inc. | 2 | $34 |
| Incyte Corporation | 1 | $24 |
Products named: DUPIXENT, TALTZ, OTEZLA, TREMFYA, WAYRILZ, COSENTYX, Bimzelx, CIBINQO.
Industry payments across KS — which companies pay providers there.
